Benova Healthcare

Newsletter #3

15th October 2026
Regulatory Update
Turmeric curcumin capsules

This week's insight

Turmeric and curcumin are in the spotlight, and this is how we're helping brands launch with confidence

Image: turmeric curcumin capsules

A favourite with new guidance

Turmeric and curcumin are still among the most loved ingredients in supplements, well beyond joints, from active lifestyles to digestive and everyday wellness. Over the past few years, regulators in several regions have taken a closer look at them, and 2026 has brought more of the same.

The good news: nothing has been banned. What regulators are asking for is sensible: reasonable doses, clear labels, and helpful guidance for people with liver conditions or on medication. The attention is on rare liver reactions in a small number of people who take supplements. Turmeric as a food spice isn't the concern.

A quick note on absorption: curcumin is hard for the body to take up, so many products add helpers such as black pepper extract or special micro-sized forms. These versions can deliver more curcumin than a standard one, so regulators are paying them closer attention.

At Benova Healthcare, we've been following every update. We know what's changing, and we help brands build turmeric and curcumin products around it.

Where things stand today

What authorities have said so far:

  • Europe: there is no EU-wide rule. Italy asks for a short advisory note on labels and no longer allows certain health claims for turmeric. France's food safety agency suggested a daily limit for curcumin in 2022.
  • UK: the government's food safety advisers (December 2024) stressed staying within recommended daily amounts, with extra care for people with liver conditions or on medicines.
  • Canada: Health Canada's safety review (September 2025) asks for simple liver-health guidance on labels.
  • USA: the standards body USP published a review in June 2026 and recommends a short label note. It's a recommendation, not a law.
  • Brazil: since April 2026, labels carry a short advisory note.
  • South Korea: the food safety ministry is reviewing turmeric extract in 2026, with findings expected by the end of the year.

How Benova Healthcare is helping

As a CDMO, we help brands turn a good turmeric idea into a product that's ready for today's expectations, without losing what makes it appealing.

  • Sensible doses and formulas. We help you set a per-serving dose that fits the guidance, and talk through whether an absorption booster is really needed.
  • Labels and claims, checked early. We flag market-specific label notes and claim restrictions up front, before anything goes to print.
  • Paperwork you can rely on. We provide specifications and testing documentation for the raw materials we use, so your regulatory team has what it needs.
  • Made-to-order, or ready to go. Develop something new with us, or start from a market-ready product and make it your own.

Your turmeric checklist

  • Daily dose per serving checked against guidance in each market you sell into
  • You know whether your formula uses an absorption booster, and have the data to explain it
  • Raw material specifications and certificates of analysis on file
  • Clear serving instructions: how much, how often
  • Label notes in place where needed, such as liver conditions, pregnancy and medication
  • Claims reviewed country by country, as some markets limit wording
  • Selling into Italy, Canada, Brazil or South Korea? Local requirements confirmed

Let's plan it together

Turmeric isn't going anywhere. Brands that build in sensible dosing and clear labels from day one can keep selling a much-loved ingredient with confidence.

Market-ready and waiting for your brand:

  • Turmeric Curcumin Gummy, lemon flavour
  • Turmeric Curcumin Joint Complex, capsule

Get in touch

Planning a turmeric or curcumin launch?

Get in touch with the Benova Healthcare team. We'll help you develop a product that's ready for today's expectations, or point you to an alternative from our range if you'd like to diversify.

Email us at info@benova-healthcare.com →
Sources: UK Committee on Toxicity, COT/2024/07 (Dec 2024); Health Canada, Summary Safety Review on turmeric and curcuminoids (Sept 2025); USP review, Pharmaceutical Biology (online 27 June 2026); Italian Ministry of Health decree of 28 July 2022, via FoodNavigator and Food Compliance International; ANSES (France, 2022), via a-r.com; ANVISA (Brazil), rules of 22 April 2026; Korea MFDS, 2026 re-evaluation of nine ingredients, via NutraIngredients (3 Feb 2026); NutraIngredients timeline on turmeric regulation (24 Aug 2026); Linus Pauling Institute; BANT (Apr 2025); Mordor Intelligence (2026); UK ASA ruling, Healthspan Ltd (2017); Benova Healthcare product catalogue.